02246nas a2200241   4500000000100000008004100001653001800042653001200060653001500072653001200087653003400099100001500133700002000148700001800168700001200186700001200198245010500210856005000315300001200365490000700377520160600384022001401990       2018                            d10aMental Health10aleprosy10aDepression10aAnxiety10aProgressive muscle relaxation1 aRamasamy S1 aPanneerselvam S1 aGovindharaj P1 aKumar A1 aNayak R00aProgressive muscle relaxation technique on anxiety and depression among persons affected by leprosy.  uhttps://www.e-jer.org/upload/jer-14-3-375.pdf  a375-3810 v143 a<p>Anxiety and depression have been found to be increasing among people with leprosy and it may lead to decreased social participation. The progressive muscle relaxation technique (PMRT) is widely used today in choice of treatment for reducing the anxiety and depression. This study aimed to assess the effectiveness of PMRT in reducing anxiety and depression among the hospitalized leprosy affected person in a tertiary care centre. This study is a case series of 50 leprosy affected people aged between 18-60 years who were admitted for leprosy complications in tertiary leprosy referral hospital. The Anxiety-Depression scale was developed and validated by the investigators and administered before intervention of PMRT and after 2 weeks. The follow-up assessment was done at 6 weeks after the initial intervention. The finding shows that a statistically significant difference was observed on anxiety domain before and after application of PMRT. The anxiety means score showed steady decline from 6.76 at pretest to 3.0 (=25.068, ≤0.001) at post test and 1.12 (=22.679, ≤0.001) at follow-up. In depression domain, a statistically significant difference was seen in before and after application of PMRT. The depression means score showed steady decline from 6.92 at pre test to 3.28 (=16.082, ≤0.001) at post test and to 1.16 (=18.918, ≤0.001) at follow-up. This study proved that the PMRT as a valid treatment option for hospitalized person with leprosy in minimizing the anxiety and depression related symptoms and to benefit the psychosocial wellbeing of leprosy affected patients.</p>
  a2288-176X